deltatrials
Terminated PHASE3 NCT00014586

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

Randomized Phase III Step-Up Study On Initial Antiandrogen Monotherapy In Comparison With Watchful Waiting In Asymptomatic T1-3 Any G (Any Gleason) NO or Nx M0 Prostate Cancer Patients Without Local Treatment With Curative Intent

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Prostate Cancer
Interventions bicalutamide goserelin acetate orchiectomy
Updated 5 times since 2017 Last updated: Sep 20, 2012 Started: Jan 31, 2001 Primary completion: Feb 28, 2003

This PHASE3 trial investigates Prostate Cancer and is currently terminated or withdrawn. European Organisation for Research and Treatment of Cancer - EORTC leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Jan 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • European Organisation for Research and Treatment of Cancer - EORTC
Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bremen, Germany